Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,035,260 papers from all fields of science
Search
Sign In
Create Free Account
tasidotin
A third generation, synthetic, water-soluble, pentapeptide analog of the marine depsipeptide dolastatin 15, with potential antimitotic and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Narrower (2)
ILX 651
tasidotin hydrochloride
Microtubule Process
NCIt Antineoplastic Agent Terminology
Broader (1)
Oligopeptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Microalgae as a source of high-value bioactive compounds.
M. Bule
,
I. Ahmed
,
Faheem Maqbool
,
M. Bilal
,
Hafiz M.N. Iqbal
Frontiers in Bioscience
2018
Corpus ID: 9728082
Microalgae are one of the oldest microorganisms, that grow in various hostile environments, ranging from deserts to Antarctica…
Expand
Review
2015
Review
2015
Anticancer compounds from cyanobacterium Lyngbya species: a review
S. S. Swain
,
R. Padhy
,
P. Singh
Antonie van Leeuwenhoek
2015
Corpus ID: 254239794
The use of synthetic anticancer drugs and other methods followed in cancer therapy have several side effects; and ineffective…
Expand
2013
2013
Mechanism of mitotic arrest induced by dolastatin 15 involves loss of tension across kinetochore pairs
Manu Lopus
Molecular and Cellular Biochemistry
2013
Corpus ID: 12268937
Dolastatin 15 (DL15) is a potent, tubulin-targeted, vinca-site binding, anticancer agent that induces mitotic arrest and inhibit…
Expand
2009
2009
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates
L. Kilburn
,
P. Bonate
,
+6 authors
S. Berg
Cancer Chemotherapy and Pharmacology
2009
Corpus ID: 1525424
PurposeTo evaluate the plasma and cerebrospinal fluid (CSF) pharmacokinetics and CSF penetration of tasidotin and metabolites in…
Expand
2009
2009
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents
L. Kurtzberg
,
Stephanie Roth
,
+6 authors
B. Teicher
Cancer Chemotherapy and Pharmacology
2009
Corpus ID: 26035169
PurposeThe dynamic instability of microtubules in cells is one of the key targets of anticancer therapeutics. Microtubule…
Expand
Highly Cited
2007
Highly Cited
2007
Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate.
Anasuya Ray
,
Tatiana Okouneva
,
+6 authors
L. Wilson
Cancer Research
2007
Corpus ID: 10689588
Tasidotin (ILX-651), an orally active synthetic microtubule-targeted derivative of the marine depsipeptide dolastatin-15, is…
Expand
2005
2005
A Phase I Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously Daily for 5 Consecutive Days Every 3 Weeks in Patients with Advanced Solid Tumors
S. Ebbinghaus
,
E. Rubin
,
+6 authors
L. Hammond
Clinical Cancer Research
2005
Corpus ID: 8475480
Purpose: To determine the maximum tolerated dose, dose-limiting toxicity, and pharmacokinetics of the dolastatin-15 analogue…
Expand
2005
2005
Phase I and Pharmacokinetic Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously on Days 1, 3, and 5 Every 3 Weeks in Patients with Advanced Solid Tumors
C. Cunningham
,
L. Appleman
,
+10 authors
J. Eder
Clinical Cancer Research
2005
Corpus ID: 37648356
Purpose: To determine the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacokinetics of tasidotin (ILX651…
Expand
Review
2005
Review
2005
Tasidotin HCl (Genzyme).
K. Rasila
,
C. Verschraegen
Current opinion in investigational drugs
2005
Corpus ID: 43323623
2005
2005
Plaunotol inhibits gastric cancer cells by induction of apoptosis
J. Yamada
,
K. Kawai
,
+10 authors
H. Nagawa
2005
Corpus ID: 199595690
5903 BACKGROUND AND AIM: Plaunotol, a kind of isoprenoid, is an anti-gastric ulcer agent, available for clinical use since more…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE